ExpreS2ion Biotech Holding AB

Prospectus ID: 26-4187

Document type
Standalone prospectus
Home member state
Sweden
Prospectus type
Standalone Prospectus
Structure
Single document prospectus
Approval / filing date
14 Apr 2026
National document ID
26-4187
Issuer LEI
549300FJK50P1ORYJC45
Language(s)
Swedish

ISINs

  • SE0023261292
  • SE0028501122

Passported to

Member states to which this prospectus has been notified under Art. 25 of Regulation (EU) 2017/1129.

  • Denmark

Comment

EU Follow-on Prospectus - 14B, which refers to issuers under Art. 14a(1)(b)

Last verified: 2 Nov 2026

Data sourced from the ESMA prospectus register, updated weekly.

Regulatory Q&As

Browse Prospectus Regulation Q&As → Official ESMA interpretations

See also

Passporting details — 1 host member state → ESMA Prospectus Passporting Register

📋 Track EU financial regulation continuously

Forseti monitors EU financial regulation and delivers personalised alerts anchored to verified official sources.

Start free trial → Learn more

14-day free trial. No credit card required.